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In Brief
 
A Profusion of Sorting Pathways
 
Retention in the Golgi
 
Little is known about how proteins are retained in the
Golgi complex. For the budding yeast protein Mnn1p, ei-
ther the transmembrane domain or the lumenal domain is
sufficient for retention. On page 935, Reynolds et al. re-
port that the MAP kinase Hog1p is needed for retention
mediated by the lumenal domain. Hog1p is part of a path-
way for sensing hyperosmotic stress, and Reynolds et al.
find that other components of this pathway are necessary
for localization of the Mnn1p lumenal domain.
Without Hog1p, the lumenal domain is secreted, whereas
the full-length protein slips from earlier Golgi compart-
 
ments to the 
 
trans
 
-Golgi network. Whether this affects
 
the 
 
a
 
-1,3-mannosyltransferase function of Mnn1p is not
known. It is certainly possible, since the lumen of later
Golgi compartments may differ in acidity, divalent cation
concentrations, or the availability of sugar nucleotide do-
nors.
A change in Mnn1p activity could alter the cell wall,
which contains a large number of mannoproteins. Rey-
nolds et al. suggest that Hog1pÕs effects on Mnn1p local-
ization may be one way that Hog1p loosens the cell wall
to allow expansion and growth. The Hog1p pathway is
known to induce the expression of an exoglucanase, which
digests various components of the cell wall, and to repress
the protein kinase C pathway, which turns on cell wall bio-
synthesis in budding yeast. Clearly, Hog1p is not the reten-
tion protein that Reynolds et al. were originally seeking,
but its discovery in this context raises intriguing questions
about how Golgi protein localization might be dynami-
cally regulated.
 
From Early Endosomes to Golgi
 
Evidence of a trafficking pathway from early endosomes
to the Golgi is presented by Mallard et al. on page 973.
This is distinct from the Golgi-bound pathway taken
by the cation-independent mannose 6-phosphate receptor
(CI-MPR). After delivering lysosome-bound proteins to
the late endosome, the CI-MPR returns directly from late
endosomes to the Golgi.
Mallard et al. use the movements of Shiga toxin B-sub-
unit to define the pathway. The B-subunit is internalized
at 19.5
 
8
 
C. It remains in early endosomes, already partition-
ing away from the bulk fluid phase in tubular structures
that often contain the AP1 coat protein 
 
g
 
-adaptin. After a
shift to 37
 
8
 
C, the B-subunit moves directly to the Golgi
with a half-time of 19 min. The authors never see any
B-subunit in late endosomes or lysosomes.
Candidates for endogenous proteins that may use this
pathway include TGN38, a protein whose function is not
known, and the protease furin, which operates in several
compartments from the Golgi to the plasma membrane.
 
Two Ways to Make a Synaptic Vesicle
 
Synaptic vesicles (SVs) must be rapidly recreated after
they have released their contents by fusing with the
plasma membrane. In vivo evidence suggests that dy-
namin, clathrin, and the AP2 adaptor complex are in-
volved in forming synaptic vesicles directly from the
plasma membrane. But an in vitro model of SV formation
identified endosomes as the source of SVs; in this case, SV
formation requires ARF1 and the AP3 adaptor but not dy-
namin or AP2.
Shi et al. solve this contradiction on page 947. Although
they set out to observe an earlier step in the in vitro path-
way (the generation of endosomes [the SV precursor]
from plasma membranes), what they saw was formation of
SVs directly from the plasma membrane, as is seen in vivo.
Apparently, the method originally used to load mem-
branes with labeled SV components favored the labeling
of endosomes. Shi et al. now observe that SVs form from
both endosomes and plasma membrane with equal effi-
ciency. The plasma membrane pathway requires dynamin,
clathrin, and AP2, but the AP3/endosome pathway does
not appear to require clathrin. There have been conflicting
reports on whether clathrin is involved in AP3-based traf-
ficking.
Several questions remain. For the plasma membrane
pathway to work, there must be a mechanism for sorting
proteins into different membrane domains before vesicle
formation. And, says senior author Regis Kelly, Òwhat we
donÕt have is what AP3 does in real neurons.Ó Mice mu-
tant for an AP3 component are viable but have a variety of
neurological defects. So the plasma membrane pathway
appears to be the major pathway in most neurons, whereas
the endosome pathway may operate only in certain types
of neurons, or at particular levels of synaptic activity.
 
Nuclear Import without Importins
 
On page 875, Jenkins et al. show that signal-mediated
transport of the HIV Vpr protein into the nucleus does not
require exogenous energy or any soluble proteins, includ-
ing the importins. Classic nuclear localization sequences
bind to importin 
 
a
 
, which binds importin
 
 b
 
, which binds
the nuclear pore complex (NPC). The GTPase Ran is
needed for this transport pathway. Nuclear transport me-
diated by a family of importin 
 
b
 
Ðrelated proteins is also
thought to rely on Ran function since these proteins con-
tain Ran binding sites. (Transport is not RanÕs only role:
on page 1041, Nakamura et al. find that overproduction of
a Ran-binding protein leads to ectopic microtubule nucle-
ation sites.)
Vpr transport does not involve Ran or the importinsÑ
neither a dominant-negative Ran nor the importin 
 
b
 
Ðbind-
ing fragment of importin 
 
a 
 
prevent Vpr transportÑbut the
transport pathways may converge. Excess importin 
 
b
 
blocks Vpr transport, and excess Vpr fragments block im-
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portin-mediated transport of other proteins. Thus, Vpr
and importin 
 
a 
 
may be binding the same NPC target.
Vpr increases the productivity of an HIV infection, but
it is not known which step is accelerated. One possible site
of Vpr action is nuclear entry of the HIV preintegration
complex. Although this process does not absolutely re-
quire Vpr, it may be facilitated by VprÕs direct access to
NPC proteins.
 
Kinesin Inhibition
 
Kinesin in vitro stays glued to a microtubule and moves
processively, in contrast to myosin moving on actin. But
like myosin, most of the kinesin in the cell is soluble. Ver-
hey et al. (page 1053) suggest that the kinesin light chain
prevents most of the motile heavy chain from binding mi-
crotubules.
With kinesin binding only rarely to microtubules, its
apparent microtubule-stimulated ATPase activity is low.
Proteolysis of kinesin heavy chain increases the ATPase
activity, so David Hackney suggested that the tail domain
folds back to inhibit the motor domain. Hackney went on
to show that at least some kinesin is found in a folded con-
formation, although he did not demonstrate a correlation
between this conformation and inhibition.
Verhey et al. find evidence to support the folding model:
a portion of the heavy chainÕs tail is needed for self-inhibi-
tion. However, they identify light chain as a key to the in-
hibition in cells. Overexpressed heavy chain decorates mi-
crotubule-like structures in cells and can be isolated bound
to taxol-stabilized microtubules. Coexpression of light
chain eliminates both heavy chainÕs in vivo localization
and in vitro binding to microtubules.
Inhibition can be released in vitro by a pH shift from 7.2
to 6.8, for both overexpressed and endogenous kinesin.
The pH shift does not involve a change in the amount of
folded or extended forms.
Artificial acidification in vivo also induces movement, in
this case of lysosomes and late endosomes to the cell pe-
riphery. A global pH change is highly unlikely to occur
naturally, but leakage of hydrogen ions from the acidic in-
terior of organelles could activate motors locally.
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